This is a demo store. No orders will be fulfilled.

Bebtelovimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, Human IgG1, INHIBITOR of Spike glycoprotein inhibitor, INHIBITOR of Spike glycoprotein inhibitor

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: SARS-CoV-2
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab175465
Grouped product items
SKU Size
Availability
Price Qty
Ab175465-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$59.90
Ab175465-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$259.90
Ab175465-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$669.90
Ab175465-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,079.90

Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Bebtelovimab (anti-Spike RBD) - Primary antibody, specific to Spike RBD, Human IgG1, INHIBITOR of Spike glycoprotein inhibitor
Synonyms Anti-Spike RBD antibody | Anti-Human Spike RBD Recombinant Antibody | Anti-Spike RBD Reference Antibody | SARS-CoV-2 antibody | Anti-SARS-CoV-2 antibody | VIR 7831 | LY-3853113 | LY-COV1404 | Anti-Spike RBD antibody | Spike RBD antibody | Anti-Human Spike
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity Spike RBD
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action Type INHIBITOR
Mechanism of action INHIBITOR of Spike glycoprotein inhibitor
Product Description

Bebtelovimab (anti-Spike RBD) a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab (anti-Spike RBD) potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy.
Purity
≥95% (SDS-PAGE&SEC)
Endotoxin Level
≤1.0EU/mg

Product Properties

Isotype Human IgG1
Light Chain Type lambdaC2
SDS-PAGE 143.82 kDa
Purification Method Protein A purified
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2578319-11-4

Images

Bebtelovimab (anti-Spike RBD) (Ab175465) - ELISA
Immobilized Recombinant Human SARS-CoV-2 Spike Protein RBD protein (rp155929) at 1.0 μg/mL can bind Bebtelovimab (anti-Spike RBD) (Ab175465) with the EC₅₀ of 32.26 ng/mL.

Bebtelovimab (anti-Spike RBD) (Ab175465) - SEC
The purity of Bebtelovimab (anti-Spike RBD) (Ab175465) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.